サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1750829

ATPアッセイの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

ATP Assays Market Size, Share & Trends Analysis Report By Type (Luminometric ATP Assays, Enzymatic ATP Assays), By Application (Drug Discovery & Development, Clinical Diagnostics), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 180 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
ATPアッセイの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年05月21日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ATPアッセイの市場規模と動向

世界のATPアッセイ市場規模は2024年に35億6,000万米ドルと推定され、2025～2030年にかけてCAGR 7.91％で成長すると予測されています。

この背景には、迅速かつ高感度な検出方法に対する需要、製薬・バイオテクノロジー研究における用途の拡大、規制当局の承認、慢性疾患の負担増などがあります。

これらの促進要因は、ヘルスケア、研究、産業部門におけるATP測定法の重要な役割を強調するものであり、個別化医療、創薬、環境モニタリング、食品安全・品質検査、疾病管理における進歩を促進します。2022年のWHOの報告書によると、食品汚染は世界で約6億人に影響を及ぼし、下痢などの重篤な症状を含む年間200以上の疾病につながり、42万人が死亡し、3,300万人の健康寿命が失われています。

がん、糖尿病、心血管障害、感染症などの慢性疾患の有病率の増加が、診断検査や疾病管理におけるATP測定法の需要を押し上げています。世界保健機関（WHO）が2023年7月に発表した報告書によると、1億1,600万人がB型肝炎に、1,000万人がC型肝炎に罹患しており、がん、肝硬変、ウイルス性肝炎に関連した死亡につながっています。ATPレベルは細胞機能障害と疾患の進行を示すため、これらの測定は疾患の診断、予後、治療反応のモニタリングのための貴重なツールとなります。世界中のヘルスケアシステムが慢性疾患の管理という課題に直面する中、アッセイは早期発見と個別化された治療戦略を通じて、患者の予後改善に貢献します。

汚染された食品には、細菌、ウイルス、寄生虫、化学品などの有害な病原体が含まれており、重大な健康リスクをもたらしています。ATPアッセイは、微生物の存在を迅速かつ高感度に検出することにより、食品汚染と闘う上で極めて重要です。これらのアッセイはアデノシン三リン酸を測定します。アデノシン三リン酸は、すべての生きた細胞に見られる微生物活性の普遍的な指標です。ATPレベルは、食品表面、設備、加工エリアの清浄度を評価するための信頼できるマーカーとして機能します。汚染源の迅速な特定を可能にし、食品メーカー、加工業者、規制当局が食中毒を予防するために即座に是正措置を講じることができるようにします。食品加工において、これらの製品は衛生習慣をモニタリングし、洗浄手順を検証し、安全基準の遵守を確認し、サプライチェーン全体で食品の品質と安全性を維持するためにリアルタイムでの微生物モニタリングを可能にします。

技術革新は、ATPアッセイ産業を前進させる上で極めて重要な役割を果たしています。アッセイ感度、精度、自動化の進歩により、AP検出法の性能と信頼性が向上しています。メーカー各社は、生物発光、蛍光、化学発光などの最先端技術を統合し、迅速かつ正確な測定を提供する新しいプラットフォームを開発しています。例えば、プロメガ社のRealTime-Glo細胞外ATPアッセイは、ストレス、活性化、アポトーシスを受けている細胞から放出されるATPを検出するように設計された生物発光法です。免疫応答調節の重要な側面である免疫原性細胞死を誘導する可能性のある治療を評価するための極めて重要なバイオマーカーとして機能します。このような進歩は、ラボや診断環境における高性能スクリーニングや自動化ワークフローに対する需要の高まりに対応しています。

ATPアッセイ産業は、アッセイの感度、利便性、価格の向上を目指した最近の動向により、顕著な製品革新と拡大を目の当たりにしています。主要例として、BIoTiumが2025年3月にSteady-ATP HTSバイアビリティアッセイキットを発売したことが挙げられます。これは、製薬とバイオテクノロジー研究における高性能スクリーニング（HTS）アプリケーションのサポートに産業が注力していることを反映しています。新しく発売されたこのアッセイは、384ウェルフォーマットで1ウェルあたり16細胞という超高感度を提供し、5時間以上の半減期を持つ安定した発光シグナルを記載しています。シングルステップで均質なワークフローは、アッセイプロトコルを簡素化するように設計されており、オートメーションやHTSシステムと高い互換性を持っています。重要なことは、このアッセイが、CellTiter-Gloのようなプレミアム市場の代替品に匹敵する性能を提供する一方で、より利用しやすい価格帯に位置づけられていることです。この開発は、特に予算に敏感なラボや新興のバイオテクノロジー企業において、発光ATPアッセイの幅広い採用を促進し、ATPアッセイ産業全体の成長軌道を支えるものと期待されます。さらに、ユーザーフレンドリーでコスト効率に優れたアッセイへの注目は、様々な研究と品質検査領域において、リアルタイムでスケーラブルかつ高効率の細胞生存率と代謝研究を可能にする方向への市場のシフトと一致しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ATPアッセイ市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 補助市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
  • COVID-19によるATPアッセイ市場への影響
  • 地域レベルの価格分析
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第4章 ATPアッセイ市場：タイプ別、推定・動向分析

  • セグメントダッシュボード
  • ATPアッセイ市場：タイプ変動分析、2024年と2030年
    • 発光ATPアッセイ
    • 酵素ATPアッセイ
    • 細胞ベースのATPアッセイ
    • その他
    • グラスパー/クリップ

第5章 ATPアッセイ市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • ATPアッセイ市場：用途変動分析、2024年と2030年
    • 医薬品の発見と開発
    • 臨床診断
    • 環境検査
    • 食品の安全性と品質検査
    • その他

第6章 ATPアッセイ市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • ATPアッセイ市場：最終用途変動分析、2024年と2030年
    • 製薬とバイオテクノロジー企業
    • 学術研究機関
    • 病院と診断ラボ

第7章 ATPアッセイ市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析、2024年
    • Thermo Fisher Scientific
    • Promega Corporation
    • PerkinElmer Inc.
    • Becton, Dickinson and Company（BD）
    • Lonza Group Ltd.
    • Danaher Corporation
    • Abcam plc
    • Quest Diagnostics Incorporated
    • Biomerieux SA
    • 3M Company
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global ATP Assays Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Mexico ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Mexico ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Europe ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Europe ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 UK ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 UK ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Germany ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Germany ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 France ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 France ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Italy ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Italy ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Italy ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Spain ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Spain ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Spain ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Denmark ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Sweden ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Sweden ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Sweden ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Norway ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Norway ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Norway ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 53 Japan ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Japan ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Japan ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 China ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 China ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 China ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 India ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 India ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 South Korea ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 South Korea ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Australia ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Australia ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Australia ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Thailand ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Thailand ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 Latin America ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Brazil ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Brazil ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait ATP Assays Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 ATP Assays market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 ATP Assays market: Type movement analysis
  • Fig. 17 ATP Assays market: Type segment dashboard
  • Fig. 18 ATP Assays market Type outlook: Key takeaways
  • Fig. 19 Luminometric ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymatic ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Cell-based ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 ATP Assays market: Application movement analysis
  • Fig. 25 ATP Assays market Application outlook: Key takeaways
  • Fig. 26 Drug Discovery and Development ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical Diagnostics ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Environmental Testing ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Food Safety and Quality TestingATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 ATP Assays market: End use movement analysis
  • Fig. 32 ATP Assays market End use outlook: Key takeaways
  • Fig. 33 Pharmaceutical and Biotechnology Companies ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Academic and Research Institutes ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Hospital and Diagnostics Laboratories ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 44 UK ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 47 France ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy implantable Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 54 China ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 55 India ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators
目次
Product Code: GVR-4-68040-390-2

ATP Assays Market Size & Trends:

The global ATP assays market size was estimated at USD 3.56 billion in 2024 and is projected to grow at a CAGR of 7.91% from 2025 to 2030. This is attributed to the demand for rapid and sensitive detection methods, expanding applications in pharmaceutical and biotechnology research, regulatory approvals, and the rising burden of chronic diseases.

These drivers underscore the critical role of ATP assays in healthcare, research, and industrial sectors, facilitating advancements in personalized medicine, drug discovery, environmental monitoring, food safety and quality testing, and disease management. The 2022 WHO report highlights that food contamination affects about 600 million people globally, leading to over 200 diseases annually, including severe conditions such as diarrhea, resulting in 420,000 deaths and 33 million healthy life years lost.

The increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and infectious diseases, drives the demand for ATP assays in diagnostic testing and disease management. According to the report published by World Health Organization (WHO) in July 2023, 116 million people live with hepatitis B and 10 million with hepatitis C, leading to cancer, liver cirrhosis, and viral hepatitis-related deaths, and around 3 million new infections occur annually, with most going undetected in the Western Pacific Region. ATP levels are indicative of cellular dysfunction and disease progression, making these assays valuable tools for disease diagnosis, prognosis, and monitoring therapeutic responses. As healthcare systems worldwide face the challenge of managing chronic conditions, assays contribute to improving patient outcomes through early detection and personalized treatment strategies.

Contaminated food contains harmful pathogens such as bacteria, viruses, parasites, and chemical substances, posing significant health risks. ATP assays are pivotal in combating food contamination by swiftly and sensitively detecting microbial presence. These assays measure adenosine triphosphate, a universal indicator of microbial activity found in all living cells. ATP levels serve as reliable markers for assessing cleanliness in food surfaces, equipment, and processing areas. They enable prompt identification of contamination sources, empowering food manufacturers, processors, and regulators to take immediate corrective actions to prevent foodborne illnesses. In food processing, these products monitor hygiene practices, validate cleaning procedures, ensure compliance with safety standards, and enable real-time microbial monitoring to uphold food quality and safety across supply chains.

Technological innovations play a pivotal role in driving the ATP assays industry forward. Advances in assay sensitivity, accuracy, and automation have enhanced the performance and reliability of AP detection methods. Manufacturers are developing novel platforms that integrate cutting-edge technologies such as bioluminescence, fluorescence, and chemiluminescence to provide rapid and precise measurements. For instance, The RealTime-Glo Extracellular ATP Assay by Promega Corporation is a bioluminescent method designed to detect ATP released from cells undergoing stress, activation, or apoptosis. It serves as a pivotal biomarker for assessing treatments that may induce immunogenic cell death, a significant aspect of immune response modulation. These advancements cater to the growing demand for high-throughput screening and automated workflows in research laboratories and diagnostic settings.

The ATP assays industry is witnessing notable product innovation and expansion, with recent developments aimed at enhancing assay sensitivity, convenience, and affordability. A key example is Biotium's launch of the Steady-ATP HTS Viability Assay Kit in March 2025, which reflects the industry's focus on supporting high-throughput screening (HTS) applications in pharmaceutical and biotech research. The newly launched assay offers ultra-high sensitivity, detecting as few as 16 cells per well in a 384-well format, and delivers a stable luminescent signal with an extended half-life of over 5 hours. Its single-step, homogeneous workflow is designed to simplify assay protocols, making it highly compatible with automation and HTS systems. Importantly, the assay delivers performance comparable to premium market alternatives, such as CellTiter-Glo, while being positioned at a more accessible price point. This development is expected to drive broader adoption of luminescent ATP assays, particularly in budget-sensitive research laboratories and emerging biotech companies, supporting the overall growth trajectory of the ATP assays industry. Furthermore, the focus on user-friendly and cost-effective assays aligns with the market's shift toward enabling real-time, scalable, and high-efficiency cell viability and metabolic studies across various research and quality testing domains.

Global ATP Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global ATP assays market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Luminometric ATP Assays
  • Enzymatic ATP Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
  • Cell-based ATP Assays
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Drug Discovery & Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety & Quality Testing
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospital & Diagnostics Laboratories
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Norway
    • Sweden
    • Denmark
    • Spain
    • Italy
    • France
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. ATP Assays Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape
  • 3.3. Impact of COVID 19 on ATP Assays market
  • 3.4. Pricing Analysis, at Regional Level
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. MEA

Chapter 4. ATP Assays Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. ATP Assays Market: Type Movement Analysis, 2024 & 2030 (USD Million)
    • 4.2.1. Luminometric ATP Assays
      • 4.2.1.1. Luminometric ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Enzymatic ATP Assays
      • 4.2.2.1. Enzymatic ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Cell-based ATP Assays
      • 4.2.3.1. Cell-based ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Graspers/ Clips

Chapter 5. ATP Assays Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. ATP Assays Market: Application Movement Analysis, 2024 & 2030 (USD Million)
    • 5.2.1. Drug Discovery and Development
      • 5.2.1.1. Drug Discovery and Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Clinical Diagnostics
      • 5.2.2.1. Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Environmental Testing
      • 5.2.3.1. Environmental Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Food Safety and Quality Testing
      • 5.2.4.1. Food Safety and Quality Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.5. Others
      • 5.2.5.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. ATP Assays Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. ATP Assays Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
    • 6.2.1. Pharmaceutical and Biotechnology Companies
      • 6.2.1.1. Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Academic and Research Institutes
      • 6.2.2.1. Academic and Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Hospital and Diagnostics Laboratories
      • 6.2.3.1. Hospital and Diagnostics Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. ATP Assays Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. Thermo Fisher Scientific
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Promega Corporation
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. PerkinElmer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Becton, Dickinson and Company (BD)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Lonza Group Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Danaher Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Abcam plc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Quest Diagnostics Incorporated
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biomerieux SA
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. 3M Company
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives